Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.113310 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Ching-Yao Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, High-Throughput Nucleotide Sequencing, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: jyshih@ntu.edu.tw.
- Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
- Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
- Deparment of Medical Affairs, Guardant Health AMEA, Singapore.
- Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Zitieren
APA
Yang, C. Y., Shih, J. Y., Liao, W. Y., Ho, C. C., Hsu, C. L., Tsai, T. H., Wu, S. G., Lin, Y. T., Hsu, W. H., Jain, S., Olsen, S., Yang, J. C., Yu, C. J., & Yang, P. C. (2023). Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113310
Vancouver
Yang CY, Shih JY, Liao WY, Ho CC, Hsu CL, Tsai TH, et al. Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113310
BibTeX
@article{Yang2023,
author = {Yang, Ching-Yao and Shih, Jin-Yuan and Liao, Wei-Yu and Ho, Chao-Chi and Hsu, Chia-Lin and Tsai, Tzu-Hsiu and Wu, Shang-Gin and Lin, Yen-Ting and Hsu, Wei-Hsun and Jain, Suyog and Olsen, Steve and Yang, James Chih-Hsin and Yu, Chong-Jen and Yang, Pan-Chyr},
title = {Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.113310}
}
EUVIMED